
Loading, please wait...

Loading, please wait...

Understanding radiation injury dose-rate dependency is essential for improving clinical risk assessments and radiotherapy protocols. Recent research has shown that ionizing radiation elicits complex cellular responses. These responses change significantly based on both the total dose and the speed of delivery. Specifically, researchers applied an integrative multi-omics approach to human lymphocytes. They combined transcriptomic and proteomic profiling to see how varying dose rates alter molecular outcomes. Consequently, this study provides a deeper look into the biological pathways affected by radiation exposure.
The study analyzed peripheral blood from fourteen healthy donors exposed to X-rays at different rates. One group received radiation at 0.05 Gy/minute, while another received 1.0 Gy/minute. Notably, the team adjusted for covariates like age, sex, and leukocyte counts. This rigorous method ensured that the results accurately reflected the impact of the dose rate itself. Furthermore, the findings revealed that lower dose rates often allow for different gene and protein expression patterns compared to acute exposures. Thus, the rate of delivery is just as critical as the total dose in determining cellular damage.
Integrating transcriptomics and proteomics helps identify key molecular signatures for radiation exposure. This is particularly useful in oncology for predicting patient sensitivity to treatment. Moreover, these molecular insights assist radiologists in refining safety guidelines for occupational exposure. Therefore, moving beyond a single-omics view allows for a more comprehensive understanding of radiation effects. Additionally, the study highlights how specific pathways, such as DNA repair and cellular stress, respond uniquely to different dose intensities. Such knowledge eventually supports more personalized clinical decisions in radiation medicine.
Dose-rate dependency suggests that slower delivery rates may allow cells more time to activate repair mechanisms. Consequently, this can lead to different survival outcomes compared to high-intensity, rapid exposures.
Multi-omics combines data from genes and proteins to give a fuller picture of cellular stress. Therefore, it captures complex interactions that a single analysis might overlook.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This multi-omics study investigates how different X-ray dose rates alter gene and protein expression in human lymphocytes for better radiation risk assessme...
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today